News Release: UNC Health-Anchored MOB Sold in Chapel Hill, NC

Colliers U.S. Healthcare Capital Markets is pleased to announce the successful closing of Texas Oncology Central Austin, a premier two-story, 29,400-square-foot facility purpose-built for Texas Oncology – a wholly owned subsidiary of U.S. Oncology, itself part of McKesson Corporation (NYSE: MCK). The property is fully leased to Physician Reliance LLC (d/b/a Texas Oncology), the largest independent oncology practice in Texas and a key member of The U.S. Oncology Network, one of the nation’s most extensive networks of community-based cancer care.

This state-of-the-art “Center for Excellence” delivers comprehensive oncology services under one roof, including medical and radiation oncology, laboratory services, and a full-service pharmacy. Texas Oncology Central Austin features advanced technology such as a Varian Linear Accelerator with RapidArc capability, reducing treatment times significantly, along with specialized areas for dosimetry, X-ray, and CT simulation. Designed for efficiency and patient convenience, the Property supports a high standard of care for a rapidly growing and affluent population in Austin, TX.